| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Jul 9 | MPLAN | 25 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Jul 8 | MPLAN | 1,015 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jul 9 | SPLAN | 25 | $16.00 | $400 |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jul 9 | MPLAN | 25 | $1.01 | $25 |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jul 8 | SPLAN | 1,015 | $16.00 | $16K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jul 8 | MPLAN | 1,015 | $1.01 | $1K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Jul 1 | MPLAN | 4,183 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Jun 30 | MPLAN | 28,826 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jul 1 | SPLAN | 2,501 | $16.24 | $41K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jul 1 | SPLAN | 5,852 | $15.67 | $92K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jul 1 | MPLAN | 4,183 | $1.01 | $4K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jun 30 | SPLAN | 28,826 | $16.04 | $462K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jun 30 | MPLAN | 28,826 | $1.01 | $29K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jun 1 | SPLAN | 4,170 | $13.16 | $55K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | May 1 | SPLAN | 300 | $13.84 | $4K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | May 1 | SPLAN | 3,870 | $13.06 | $51K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Apr 6 | SPLAN | 4,170 | $13.43 | $56K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Mar 2 | SPLAN | 4,170 | $15.01 | $63K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Feb 25 | MPLAN | 3,824 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Feb 24 | MPLAN | 4,300 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 25 | SPLAN | 3,824 | $16.01 | $61K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 25 | MPLAN | 3,824 | $1.01 | $4K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 24 | SPLAN | 4,300 | $16.03 | $69K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 24 | MPLAN | 4,300 | $1.01 | $4K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Feb 19 | MPLAN | 100 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 19 | SPLAN | 100 | $16.00 | $2K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 19 | MPLAN | 100 | $1.01 | $101 |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Feb 11 | MPLAN | 400 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 11 | SPLAN | 400 | $16.00 | $6K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 11 | MPLAN | 400 | $1.01 | $404 |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 3 | SPLAN | 1,170 | $15.25 | $18K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Feb 3 | SPLAN | 3,000 | $14.82 | $44K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Jan 30 | A | 6,500 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChiefDERIV | Jan 30 | A | 160,000 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jan 5 | SPLAN | 500 | $11.13 | $6K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Jan 5 | SPLAN | 3,670 | $10.35 | $38K |
| Contineum Therapeutics, Inc. | CTNM | Daniel S. LorrainChief | Dec 23 | SPLAN | 4,170 | $12.23 | $51K |